U.S. Measles Loses Measles Elimination Status
On November 17, 2026, the Pan American Health Organization (PAHO) announced that the United States has officially lost its measles elimination status, a designation held since 2000. This follows evidence of sustained measles transmission for more than 12 months, indicating that endemic transmission has been re-established in the country.
While this represents a significant public health setback, it also highlights the critical role of clinical laboratories in infectious disease surveillance, early detection, and outbreak response.
What does this mean for U.S. clinical laboratories?
As measles cases continue to emerge, laboratories should evaluate their operational preparedness in several key areas:
Testing Preparedness: Review molecular and serologic testing capabilities, turnaround times, and capacity for increased demand.
Specimen Collection and Referral: Ensure collection, handling, and referral procedures align with receiving laboratory requirements.
Public Health Reporting: Review state and local reporting requirements for suspected and confirmed cases.
Public Health Coordination: Maintain clear communication with health departments to support testing and outbreak response.
Staff Education and Safety: Reinforce proper specimen handling, infection prevention, and staff safety protocols.